United States · FDA National Drug Code directory

Emtricitabine and Tenofovir Disoproxil Fumarate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-2650_c7a8910e-fc5b-4378-b55c-2a17a5614e5e
Product NDC
71335-2650
Form
TABLET, FILM COATED
Composition / generic term
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20190726
Source listing expiry
20271231

Source-listed ingredients

  • EMTRICITABINE — 200 mg/1
  • TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (71335-2650-1) · 71335-2650-1
  • 3 TABLET, FILM COATED in 1 BOTTLE (71335-2650-2) · 71335-2650-2
  • 15 TABLET, FILM COATED in 1 BOTTLE (71335-2650-3) · 71335-2650-3
  • 6 TABLET, FILM COATED in 1 BOTTLE (71335-2650-4) · 71335-2650-4

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →